EUCTR2014-000647-32-SE进行中（未招募）1 期
Investigation of the efficacy of degarelix as an acute treatment for patients with pedophilic disorder to reduce the risk for sexual child molestation: a prospective, randomized, double blind, and placebo controlled study.
Karolinska University Hospital0 个研究点目标入组 60 人开始时间: 2014年4月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Male >= 18 -65 years
- •Diagnos pedophilia 302.2 according to DSM-5
- •Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diagnose of osteporosis
- •Extended QT/QTc ration on ECG (>450 ms)
- •Symptoms or riskfactors known to increase the risk for QT extension (e.g. a history or (family heridity) of cardiac events that indicate a prolongation of QT interval e.g. freqent attacs of syncopé, or propensity to ventricular tachyarrhythmias).
- •On current medical treatment with pharmaceutical substances that could increase QT interval.
- •Known liver disease/function
- •Known kidney disease/function
- •Severe asthma
- •Known allery to IMP and/or IMP excipients
- •Ongoing drugabuse, measured in AUDIT/DUDIT
- •Any indications that MRI measurement are contraindiciated (i.e. metal clips brain etc.)
- •Any other condition that could jepordize the trial scientificly or patients health, as judged by the investigator
- •Particiaption in another clincial trial
研究者
相似试验
已完成
不适用
A randomized phase II study of degarelix combined with anti-androgen for prostate cancerProstate cancerJPRN-UMIN000011506South-Kinki Prostate Cancer Study Group90
已完成
不适用
A clinical study to evaluate the efficacy of degarelix in prostate cancer patientsprostate cancerJPRN-UMIN000015128Department of Urology, Keio University School of Medicine30
Unknown
2 期
Cardiovascular Events in GnRH Agonist vs. AntagonistHormone Sensitive Prostate CancerCardiac EventProstate CancerNCT04182594Rabin Medical Center80
Unknown
不适用
Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.InfertilityPremature Ovarian FailureNCT03861715Assisting Nature180
已完成
2 期
The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate CancerProstate CancerNCT00819247Ferring Pharmaceuticals129